Boston Partners
HHS icon

Boston Partners’s Harte-Hanks HHS Stock Holding History

Boston Partners’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,930
Closed -$181K – 762
2017
Q1 		$181K Sell
12,930
-6,580
-34% -$100K ﹤0.01% 759
2016
Q4 		$295K Buy
19,510
+3,550
+22% +$53.8K ﹤0.01% 740
2016
Q3 		$259K Buy
15,960
+210
+1% +$3.46K ﹤0.01% 729
2016
Q2 		$250K Buy
+15,750
New +$278K ﹤0.01% 721
2015
Q4 		– Sell
-36,405
Closed -$1.28M – 748
2015
Q3 		$1.28M Buy
+36,405
New +$1.64M ﹤0.01% 644
2015
Q1 		– Sell
-49,823
Closed -$3.86M – 715
2014
Q4 		$3.86M Hold
49,823
– – 0.01% 569
2014
Q3 		$3.17M Hold
49,823
– – 0.01% 581
2014
Q2 		$3.58M Buy
49,823
+452
+0.9% +$34.9K 0.01% 567
2014
Q1 		$4.36M Buy
49,371
+10,685
+28% +$832K 0.01% 542
2013
Q4 		$3.02M Buy
+38,686
New +$3.15M 0.01% 578

Other funds holding HHS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Boston Partners's HHS Position: Q2 2017 in Review

Boston Partners sold out of Harte-Hanks (HHS) in Q2 2017, closing a stake of 12,930 shares — an estimated $181K sold.

Boston Partners first reported a position in HHS in Q4 2013 and held it in 10 quarters. The position peaked at $4.36M in Q1 2014. 63 funds tracked by Wall St. Rank hold HHS as of Q2 2017.

  • Boston Partners reported no remaining Harte-Hanks position as of Q2 2017 after selling out during the quarter.
  • Boston Partners sold 12,930 Harte-Hanks shares in Q2 2017, an estimated $181K.
  • Boston Partners first reported a position in Harte-Hanks in Q4 2013 and held it in 10 quarters.
  • Boston Partners's Harte-Hanks position peaked at $4.36M in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2017.

Based on Boston Partners's 13F filing for Q2 2017, filed 2 Aug 2017.